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Neural stem and progenitor cells: choosing
the right Shc
Tiziana Cataudella, Luciano Conti and Elena Cattaneo*
Department of Pharmacological Sciences and Center of Excellence on Neurodegenerative Diseases,
University of Milan, I-20133 Milan, Italy
Abstract: Neural stem cell (NSCs) are self-renewing, multipotent cells able to generate neurons, astrocytes and
oligodendrocytes. Since their identiﬁcation, these properties have made NSCs an attractive subject for therapeutic
applications to the damaged brain. In this context, understanding the mechanisms and the molecules regulating their
biological properties is important and it is focused to gain control over their proliferative and diﬀerentiative potential.
Here we will discuss values and unsolved aspects of the system and the employment of potentially key molecular targets
for proper control of NSCs fate.
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Introduction
Throughout the last decade there has been an
increasingly enthusiastic interest in the cell biology
of stem cells. These are widely considered as an
invaluable potential tool for cell therapy approaches
to a broad range of clinical conditions. According to
its deﬁnition, the main physiologic function of a stem
cell is to generate all of the diﬀerentiated cell types
of the tissue in which it resides. Indeed, a stem
cell is generally deﬁned operationally as a cell that
is: (i) multipotent, (ii) capable of self-renewal, and
(iii) capable of generating a progeny that can func-
tionally integrate into and repair the tissue of origin.
Regarding the neural stem cells (NCSs), i.e., those
stem cells residing inside the nervous system, this
implies that their progeny will include mature neu-
rons, astrocytes and oligodendrocytes. Stem cell
technology is particularly important for the central
nervous system (CNS) since cell transplantation
might help to overcome the intrinsic poor capability
of the nervous tissue to replace elements lost in the
course of injury or disease. Proper control over the
diﬀerentiation pattern of brain stem cells may there-
fore eventually allow the treatment of a wide range of
degenerative diseases characterized by neuronal or
glial loss. However, relatively little is known about
the molecular regulators and genetic cascades that
control NSCs self-renewal and multipotency. In this
article, we will review the recent advancements in the
NSCs ﬁeld aimed to improve the control of their
proliferation or diﬀerentiation, aiming at an eﬃcient
and safe future clinical employment for cell replace-
ment purposes.
Stem or progenitor cells: how to distinguish
between the two?
Cells with stem-like properties, initially identiﬁed
in the fetal, and more recently in the adult mam-
malian brain, can be grown in culture, displaying the
potential to self renew and to generate the diﬀerent
*Correspondence to: E. Cattaneo, Department of
Pharmacological Sciences and Center of Excellence on
Neurodegenerative Diseases, University of Milan, Via
Balzaretti 9, I-20133 Milan, Italy. Tel.: þ 39-02-5031-8333;
Fax: þ 39-02-5031-8284; E-mail: elena.cattaneo@unimi.it
ARTICLE IN PRESS
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
UN
CO
RR
EC
TE
D
PR
O
O
F
cell types of the nervous system (McKay, 1997).
During brain development, NSCs are localized in
the epithelial layer of the germinal zone surrounding
the ventricles (Temple, 2001). As brain maturation
continues, postmitotic neurons migrate away from
the ventricular zone, mainly guided by radially ori-
ented glial processes, and the ventricular zone dimin-
ishes in size (Rao, 1999). In the adult brain, cells with
similar stem-like properties also exist, mostly
originating from two regions: the hippocampus and
the subventricular zone (SVZ) of the lateral ventricles
(Gage, 2002). Noteworthy, diﬀerent studies indicate
that NSCs from diﬀerent fetal and adult brain areas
are not identical, as demonstrated by diﬀerent growth
characteristics, trophic factor requirements, and spe-
ciﬁc patterns of diﬀerentiation (Temple, 2001). This
is further demonstrated by in vitro experiments that
revealed that NSCs diﬀer in their potential according
to the developmental stage at which they are iso-
lated and to the site from where they were obtained
(Temple, 2001). More generally, in vitro studies indi-
cate that two types of neural stem-like cells have been
isolated in multiple brain regions and appear to
coexist. One type shows epidermal growth factor
(EGF) responsiveness and can be expanded as ﬂoat-
ing cell aggregates, called neurospheres (Reynolds
and Weiss, 1992), becoming ﬁbroblast growth factor
(FGF)-responsive with the in vitro passages (Vescovi
et al., 1993; Represa et al., 2001). The second group
has been shown to be FGF-dependent and can be
propagated both as adherent cultures as well as
neurospheres (Kalyani et al., 1997).
Importantly, all the above mentioned evidence
indicating the existence of heterogeneous NSC popu-
lations may be the consequence of the lack of a neural
stem-restricted marker for NSC prospective isolation
procedure. This implies that it is currently very diﬃ-
cult to distinguish, but posteriorly and only following
accurate clonal analysis, between a real NSC and a
progenitor. Conceptually, these two populations diﬀer
for their diﬀerentiative capabilities. Indeed, while
NSCs are multipotential, brain progenitor are gener-
ally considered to be more limited in their poten-
tial and able to produce only restricted phenotypes
(McKay, 1997). Up to date, there are only fewmarkers
of putative NSCs (nestin, sox-1, musashi, AC133,
PNAlow/HSAlow, Lex/ssea-1) that may be used with
some degree of speciﬁcity being expressed by brain
progenitors and not by other cell types (Rossi and
Cattaneo, 2002).
In the absence of a clear in vivo assay to identify
the NSCs, most authors use the ability to grow, in
vitro, neurospheres which contain cells capable to
diﬀerentiate as glia and neurons, as an operative
deﬁnition for ‘NSCs’ (Rossi and Cattaneo, 2002).
Nevertheless, this assay is not devoid of faults since
neurospheres contain cells that are clearly not
uniform in their diﬀerentiative stage and estimation
of the number of bona ﬁde stem cells contained in
a preparation of cells dissociated from neurospheres
varies as widely as for those contained in the fetal
brain (Temple, 2001; Rossi and Cattaneo, 2002;
Suslov et al., 2002). New strategies to allow eﬃcient
prospective isolation of stem cells from the brain are
highly demanded to guarantee uniformity of results
and lead to trustworthy conclusions. Increasing
attempts in this direction are ongoing by combining
sorting for cell size and antigenic properties (Rietze
et al., 2001; Capela and Temple, 2002).
Transdifferentiation, transformation, fusion:
deciphering the stem cells plasticity
Recent progress in stem cell research indicates that
certain mammalian cells maintain a high degree
of plasticity giving rise to multilineage cell diﬀeren-
tiation. Indeed, some developmental peculiarities
suggest that stem cells may be able to diﬀerentiate
into cell types that are not of the same germ layers
(Tajbakhsh et al., 1994). An early intriguing case is
that of cultured neural stem cells derived from neuro-
spheres of clonogenic origin which repopulate the
hematopoietic system in sublethally irradiated allo-
genic host by cells (Bjornson et al. 1999). Similarly, in
other studies, transplantation of adult bone marrow
cells has generated a broad range of phenotypes,
including muscle cells (Ferrari et al., 1998), liver cells
(Petersen et al., 1999; Lagasse et al., 2000), brain
cells (Brazelton et al., 2000; Mezey et al., 2000) and
other (Krause et al., 2001). This seemed to indicate
that the extracellular factors or cell-cell interaction
might be suﬃcient for reprogramming putative
somatic stem cells into a more pluripotent, embryonic
stem cell (ES)-like, condition. This hypothesis was
reinforced by the demonstration that when injected
128
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into blastocysts NSCs participate to the formation of
most of the tissues of the mouse (Clarke et al., 2000).
This hypothesis is challenged by results from various
groups. Morshead and colleagues showed that, in
their hands, putative NSCs extensively cultivated in
vitro do not turn into hematopoietic cells with any
appreciable frequence (Morshead et al., 2002). The
same authors suggested that genetic instability of
NSCs after long term in vitro expansion may explain
the original results. They suggested that the claimed
hematopoietic reconstitution could result as a conse-
quence of transformation events or artefacts due to
the in vitro procedures or methodological problems.
While this study was criticized for the possible
diﬀerent number of stem cells in the culture and the
presence of transformation events (Vescovi et al.,
2002), it seems reasonable to conclude that transdif-
ferentiation events, when present, appears to be a
much rarer phenomenon than previously described
and may be peculiar only to some cell clones. Because
of that, the clinical relevance of such data is debated.
Nevertheless, the possibility that even a few brain or
blood stem cells can transdiﬀerentiate remains of
biological interest. However, no consistent demon-
stration of cell conversion followed the original
claims, leaving the subject, at present, rather
confused.
Following the report of Bjornson et al. (1999), we
began a set of experiments aimed at assessing whether
the reported ability of NSCs to transdiﬀerentiate into
blood was acquired due to in vitro expansion (and
possible de-diﬀerentiation of the cells), or whether it
was an intrinsic property of brain stem cells
(Magrassi et al., 2003). To test this, we isolated
fetal neural cells (fNC), from E10 embryos derived of
transgenic mice expressing EGFP (at this stage the
telencephalic vesicles do not have ingrowths of
blood vessels and are highly enriched in NSCs and
progenitors). The cells were dissociated and directly
transplanted into sublethally irradiated C57Bl/6 as
performed by Bjornson et al. (1999). Analysis of
grafted animals at diﬀerent time points did not reveal
development of chimerism in the hematopoietic
compartment even after very long survival times
(16 months) after grafting. The same negative results
were obtained by injecting the fNC into the tail vein
or by transplanting them directly into the bone
marrow cavity of sublethally irradiated mice. While
we could detect donor cells by PCR and Fluorescence
Activated Cell Sorting (FACS) analyzes at the early
time points, the same assays failed to detect the
presence of circulating donor-derived fNC EGFP
positive cell on a fraction of peripheral blood
collected from the grafted animals at mid and at
late time points (i.e., 30, 60, 120 and 495 days after
grafting) (Magrassi et al., 2003). These results
indicated that NSCs do not physiologically exhibit
transdiﬀerentiative capability and that, if present, this
capability requires ex vivo expansion procedures that
would possibly reprogramme the diﬀerentiative
potential of the donor cells. This seems in agree-
ment with recent results from Verfaille’s group that
has reported the isolation of a Multipotent Adult
Progenitor cell (MAPc) able to extensively contribute
to chimerae once injected in the early blastocyst and
to repopulate all the adult tissues once transplanted
into sublethally irradiated mice (Jiang et al., 2002).
Interestingly, these cells can be established from
adult murine mesenchymal cells only after at least
20 passages in vitro, reinforcing the idea that the in
vitro expansion may somehow act to reprogram the
cells toward an ES-like potential.
However, various studies now indicate that trans-
diﬀerentiation of in vitro expanded stem cells may
be explained by fusion of donor cells with host cells
(Terada et al., 2002; Ying et al., 2002). While these
studies were showing the possibility of cell fusion
between somatic stem cells and cultured embryonic
stem cells, more recent experiments now indicate
the possibility that cell fusion may also occur
among somatic tissues after in vivo transplantation
(Vassilopoulos et al., 2003; Wang et al., 2003).
Future research is needed to establish the real abi-
lity of stem cells to transdiﬀerentiate and the impact
of this phenomena for therapeutical approaches.
Driving proliferation and differentiation events in
neural cells through Shc(s) molecules
The identiﬁcation of candidate molecular mechan-
isms able to modulate proliferation, diﬀerentiation
and, possibly, plasticity of NCSs is of great interest
in order to implement studies and trials for cell
replacement therapies. To this regard, an interesting
strategy may come from studies of signaling
129
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mechanisms downstream of growth factors receptors.
Particularly, we pointed to the regulated expression
and activity of Shc(s) adapter molecules, which cou-
ple signals from activated receptors to downstream
eﬀectors, as a potential mechanism to regulate divi-
sion, survival and diﬀerentiation on stem cells in the
brain. Shc(s) proteins indeed appear to play a role in
the control of the proliferation and subsequent matu-
ration of mitotically active neural stem/progenitor
cells into postmitotic neurons (Cattaneo and Pelicci,
1998; Conti et al., 2001).
Up to date, three Shc(s) genes have been identi-
ﬁed, named ShcA, ShcB/Sli and ShcC/Rai/N-Shc
having a consistent homology (Pelicci et al., 1992,
1996; O’bryan et al., 1996; Luzi et al., 2000). These
three Shc(s) molecules are characterized by the
presence of phosphotyrosine regulatory residues and
the PTB, CH1 (a proline rich domain) and SH2
domains in the presented order. Three isoforms are
known for ShcA (of 66, 52 and 46 kD), two isoforms
for ShcB (of 52 and 47 kD) and two for ShcC (of 54
and 69 kD). p66ShcA display a further N-terminal CH
domain (CH2) that contains important regulatory
serine residues. They share elevated homology in
both the C terminus SH2 domain and the N terminus
PTB domain, the most divergent sequence being in
the proline and glycine rich CH1 (Collagene
Homology 1) region. ShcA proteins have been
extensively characterized and shown to be widely
expressed outside the CNS. Their importance is
indicated by (i) the early embryonic lethal phenotype
of p52ShcA null mutation (Lai and Pawson, 2000), (ii)
the impairment in thymocytes development in
conditional p52ShcA knockout (Zhang et al., 2002),
and (iii) by the increase in life span and resistance
to stress stimuli in p66ShcA knockout animals
(Migliaccio et al., 1999).
Despite the apparently constitutive presence of
ShcA in extraneural tissues, ShcA expression and
activity within the brain is tightly regulated during
development and maximal in the embryonic day 10
neural tube. At later time points, ShcA remains con-
ﬁned to the germinal epithelium where mitotically
active immature stem and progenitor cells are loca-
ted. Instead, in the areas of the embryonic or post-
natal brain where postmitotic neurons are present,
mRNAShcA is highly reduced. Similarly, the adult
brain exhibited low ShcA expression, the main
exception being the olfactory epithelium, which is a
predominant area of active neurogenesis in the adult.
These changes in the expression and activity of ShcA
as a function of neuronal maturation were conﬁrmed
in vitro in diﬀerentiating neuronal cultures (Conti
et al., 1997). Not only ShcA is present in actively
dividing neurogenic areas, but is also susceptible of
being activated. Indeed, in vivo immunoprecipi-
tation of ShcA from the telencephalic vesicles of
embryonic brains injected intraventricularly with
mitogens like EGF revealed a higher phosphory-
lation of the p52ShcA isoform with respect to control
animals (Conti et al., 1997). In treated samples, Grb2
coimmunoprecipitation was also observed, indicat-
ing that ShcA is not only present in the germinal
epithelium, but it is also able to elicit a functional
response with recruitment of downstream pathways.
The demonstration that ShcA availability is
regulated during neurogenesis and becomes limited
during NSCs maturation in vivo and in vitro led to
the proposition that other Shc-like proteins may
substitute for ShcA function in mature neurons
(Cattaneo and Pelicci, 1998). Given the existence of
two more recently identiﬁed Shc members, ShcB
and ShcC, the latter being selectively expressed
in the brain, we suggested that one or both of them
could replace ShcA in mature neurons (Cattaneo
and Pelicci, 1998). Analyzes of ShcC expression
showed an opposite expression pattern with respect
to ShcA, being absent in neural progenitors but
present in early postmitotic neurons and reaching
maximal levels in the adult brain where it is found
localized only in neurons. Similar changes in ShcA
and ShcC levels during neuronal maturation have
been observed in several mammalian species (rat,
mouse and human) (Conti et al., 2001). Notably,
ShcC is found in neurons from various regions of the
adult brain thus predicting a general role played by
ShcC in these cells. Particularly, given the above
described central roles of ShcA in signal transduc-
tion, ShcC appearance in diﬀerentiating NSCs has
been hypothesized to serve diﬀerent ‘connector
functions’ compared with ShcA, allowing maturing
cells to respond diﬀerently to environmental stimuli
(Conti et al., 2001). To this regard, Lai and Pawson
(2000) demonstrated the existence of a strict link
between Shc levels and cell responsiveness. The
authors showed that ShcA expression and activity are
130
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required in cells of the cardiovascular system to make
them responsive to low concentrations of growth
factors. Indeed, while a low concentration of growth
factors is necessary to activate the MAPK pathway in
mouse embryo ﬁbroblasts (MEF), cells from ShcA
knockout mice require a higher concentration of
growth factors to activate the same signaling cascade.
Transfection experiments in primary neural cells and
in postmitotic neurons revealed that ShcC acts to
promote neuronal diﬀerentiation and improve survi-
val of these cells (Conti et al., 2001). It was also found
that ShcC elicits these eﬀects through a diﬀerent
kinetic of activation of downstream eﬀector mole-
cules with respect to ShcA. Indeed, ShcC elicits
neuronal diﬀerentiation via prolonged stimulation of
the MAPK (Conti et al., 2001; Pelicci et al., 2002).
This behavior is reminiscent of that described in
PC12 cells exposed to NGF, where persistent
activation of MAPK is required for neuronal
diﬀerentiation. On the contrary, ShcC-driven pro-
survival eﬀect occurs via recruitment of the PI3K-Akt
pathway (Conti et al., 2001; Pelicci et al., 2002), as
demonstrated by the fact that its pharmacological or
molecular inhibition markedly abolishes this eﬀect.
To this respect, ShcC-induced Akt activation was
found to cause phosphorylation (with inhibition) of
Bad, a proapoptotic member of the Bcl2 family
(Conti et al., 2001).
Single and double ShcB/C null mice have been
recently described (Sakai et al., 2000). ShcB-deﬁcient
mice exhibit a loss of peptidergic and nonpepti-
dergic nociceptive sensory neurons. ShcC null mice
appear not to show gross anatomical abnormalities.
Noteworthy, mice lacking both ShcB and ShcC
exhibit a signiﬁcant additional loss of neurons
within the superior cervical ganglia. This aspect may
emphasize that the lack of phenotype in ShcC null
mice could be due to a partial compensation by the
other ShcB or other Shc members during develop-
ment, thus masking ShcC real function in neural
tissues. Further analyzes will be required to
elucidate ShcC role in neuronal generation from
stem cells .
Taken together these results unveil a new scenario
within which physiological changes in the availability
of ShcA and ShcC adaptors during brain devel-
opment may act to modify neural stem/progenitor
cell responsiveness as a function of the new and
developing environment.
Conclusions
Fetal and adult NSCs are an important tool to be
exploited for brain repair in neurodegenerative
disease either through their transplantation or via
their in situ activation in the brain. The under-
standing of the function of candidate genes respon-
sible for proliferation and diﬀerentiation is essential
to implement studies for cell replecement therapies;
however, at present, the speciﬁcation of NSC into
the desired phenotypes is far from being eﬃciently
controlled. The prominent activities of Shc(s) pro-
teins inmodulating cell responsiveness and the demon-
stration of their regulated expression at the transition
from proliferation to diﬀerentiation in the brain,
point at the Shc(s) signaling pathways as candidate
targets for pharmacological modulation of stem cell
division and diﬀerentiation in the brain.
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Abbreviations
NSCs neural stem cells
CNS central nervous system
SVZ subventricular zone
EGF epidermal growth factor
FGF ﬁbroblast growth factor
EC embryonic stem cell
fNC fetal Neural stem and progenitor Cells
EGFP enhanced green ﬂuorescent protein
FACS ﬂuorescence activated cell sorting
MAPc multipotent adult progenitor cell
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Shc Src Homologue and Collagene
Homologue
PNA peanut agglutinin
HAS heat-stable antigen
LeX Lewis X
SSEA-1 stage-speciﬁc embryonic antigen 1
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